News

NUS researchers tap AI to improve effectiveness of Covid-19 drugs

Prof Dean Ho found that when antiviral drugs molnupiravir and Paxlovid were each combined with the protease-inhibiting drug YH-53, the mix was effective against the Omicron variant of the coronavirus in lab settings.

Read more: https://news.nus.edu.sg/nus-researchers-tap-on-ai-to-improve-effectiveness-of-covid-19-drugs/

view MORE related

News

2025
npj Precision Oncology – Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments
More Details >
2025
Singapore’s Balancing Act – Trade-offs of a Global City-state
More Details >
2025
Scientists use microcellular drones to deliver lung cancer-killing drugs
More Details >
get in touch and

Contact Us

For inquiries pertaining to our R&D Programs, please contact Khew Si Ying at khewsiying@nus.edu.sg

The Institute for Digital Medicine (WisDM)

  • 28 Medical Drive, #05-COR,
    Singapore 117456

© National University of Singapore. All Rights Reserved.